Professor Anthony Joshua completed his medical oncology training at the Royal Prince Alfred hospital in Sydney, Australia before moving to Toronto, Canada to complete a PhD in Bioinformatics. He joined the Department of Medical Oncology at Princess Margaret Cancer Centre in Toronto as a staff oncologist in late 2008, specializing in genito-urinary malignancy and melanoma with clinical and laboratory research interests in circulating tumour DNA, tumour heterogeneity, mechanisms of androgen resistance and autophagy. He returned to Australia, joining the Kinghorn Cancer Centre in late 2015 as the Head of Department of Medical Oncology, St Vincents Hospital. He is currently Clinical Science Lead, Garvan Institute of Medical Research and has leadership roles in the Melanoma and Skin Cancer Trials group, the Australian and New Zealand Urogenital Trials group as well as the New South Wales Early Phase Clinical Trials Alliance. He is a conjoint Professor with UNSW Sydney and the University of Notre Dame, Sydney.